MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 175 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,056,376,000 | +203.7% | 39,184 | +92.5% | 0.00% | +200.0% |
| Q2 2020 | $677,078,000 | -58.9% | 20,351 | -66.4% | 0.00% | -66.7% |
| Q1 2020 | $1,646,661,000 | +117.8% | 60,539 | +58.0% | 0.00% | +200.0% |
| Q4 2019 | $755,955,000 | +88.6% | 38,315 | +23.9% | 0.00% | 0.0% |
| Q3 2019 | $400,723,000 | +142.8% | 30,920 | +133.2% | 0.00% | – |
| Q2 2019 | $165,050,000 | -48.4% | 13,257 | -39.8% | 0.00% | -100.0% |
| Q1 2019 | $319,892,000 | +1575.9% | 22,016 | +1173.3% | 0.00% | – |
| Q4 2018 | $19,088,000 | -83.2% | 1,729 | -60.0% | 0.00% | – |
| Q3 2018 | $113,669,000 | +29.9% | 4,322 | +1.0% | 0.00% | – |
| Q2 2018 | $87,526,000 | -80.3% | 4,280 | -82.5% | 0.00% | -100.0% |
| Q1 2018 | $443,423,000 | +0.3% | 24,431 | -22.9% | 0.00% | 0.0% |
| Q4 2017 | $442,201,000 | -39.5% | 31,699 | -19.7% | 0.00% | -50.0% |
| Q3 2017 | $730,602,000 | +99.8% | 39,492 | +82.5% | 0.00% | +100.0% |
| Q2 2017 | $365,716,000 | +104.5% | 21,640 | +61.6% | 0.00% | – |
| Q1 2017 | $178,797,000 | +0.5% | 13,393 | +13.3% | 0.00% | -100.0% |
| Q4 2016 | $177,936,000 | +56.1% | 11,823 | +21.2% | 0.00% | – |
| Q3 2016 | $114,001,000 | -46.7% | 9,752 | -50.8% | 0.00% | -100.0% |
| Q2 2016 | $214,013,000 | +151.8% | 19,816 | +115.4% | 0.00% | – |
| Q1 2016 | $84,999,000 | -54.8% | 9,199 | -27.5% | 0.00% | – |
| Q4 2015 | $188,230,000 | -34.6% | 12,684 | -27.7% | 0.00% | -100.0% |
| Q3 2015 | $287,864,000 | +148.3% | 17,542 | +245.2% | 0.00% | – |
| Q2 2015 | $115,920,000 | +570.8% | 5,082 | +347.0% | 0.00% | – |
| Q1 2015 | $17,282,000 | -46.6% | 1,137 | -60.2% | 0.00% | – |
| Q3 2014 | $32,387,000 | +199.3% | 2,856 | +366.7% | 0.00% | – |
| Q4 2013 | $10,820,000 | -94.1% | 612 | -95.2% | 0.00% | – |
| Q3 2013 | $184,365,000 | -24.2% | 12,812 | -20.6% | 0.00% | – |
| Q2 2013 | $243,114,000 | – | 16,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |